NCT02001935View on ClinicalTrials.gov

Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

theophylline

After oral theophylline 200mg per day for two weeks,bood sample will be collected for determining plasma concentrations of theophylline and it's metabolites and the genotypes of CYP1A2 and CYP2E1

Trial Locations (1)

510282

Zhujiang Hospital,Southern Medical Universtiy, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER

NCT02001935 - Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline | Biotech Hunter | Biotech Hunter